Athira Pharma (ATHA.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov7

Athira Pharma released FY2025 9 Months Earnings on November 6, 2025 (EST) with actual revenue of USD 0 and EPS of USD -5.7999

04:00

Athira Pharma released FY2025 Q3 earnings on November 6, 2025 (EST), with actual revenue of USD 0 (forecast USD 0) and actual EPS of USD -1.6762 (forecast USD -1.22)

04:00

Aug14

Athira Pharma Announces Encouraging Phase 1 Trial Results for ALS Treatment Candidate ATH-1105

11:01

Aug8

Athira Pharma released FY2025 Q2 earnings on August 7 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.7819 (forecast USD -1.4)

03:00

Athira Pharma released FY2025 Semi-Annual earnings on August 7 (EST) with actual revenue of USD 0 and EPS of USD -0.4123

03:00

Aug7

Athira Pharma Reports Narrowed Net Loss in Q2

20:07

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -6.611 M, EPS -1.6762

Sep18

Reverse Stock Split(EST)

1-for-10 Reverse Stock Split

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -6.966 M, EPS -1.7819

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More